Luseogliflozin: First Global ApprovalMARKHAM, Anthony; ELKINSON, Shelley.Drugs (Basel). 2014, Vol 74, Num 8, pp 945-950, issn 0012-6667, 6 p.Article

Standard and intensive lipid-lowering therapy with statins for the primary prevention of vascular diseases: a population-based studyMACIAS SAINT-GERONS, D; DE LA FUENTE HONRUBIA, C; MONTERO COROMINAS, D et al.European journal of clinical pharmacology. 2014, Vol 70, Num 1, pp 99-108, issn 0031-6970, 10 p.Article

Combining a GLP-1 Receptor Agonist and Basal Insulin: Study Evidence and Practical ConsiderationsCARRIS, Nicholas W; TAYLOR, James R; GUMS, John G et al.Drugs (Basel). 2014, Vol 74, Num 18, pp 2141-2152, issn 0012-6667, 12 p.Article

New Trends in Polymyxin B Hemoperfusion: From 2006 to 2013CRUZ, Dinna N.Blood purification. 2014, Vol 37, pp 9-13, issn 0253-5068, 5 p., SUP1Article

Hyponatremia: an update on current pharmacotherapySHCHEKOCHIKHIN, Dmitry; TKACHENKO, Oleksandra; SCHRIER, Robert W et al.Expert opinion on pharmacotherapy. 2013, Vol 14, Num 6, pp 747-755, issn 1465-6566, 9 p.Article

Lorcaserin: A Review of its Use in Chronic Weight ManagementHOY, Sheridan M.Drugs (Basel). 2013, Vol 73, Num 5, pp 463-473, issn 0012-6667, 11 p.Article

Liptruzet: une combinaison d'ézétimibe et d'atorvastatine = Liptruzet: a combination of ezetimibe and atorvastatinThe Medical letter on drugs and therapeutics (Edition française). 2013, Vol 35, Num 15, pp 57-58, issn 0253-8512, 2 p.Article

exénatide (BYETTA°) associé avec l'insuline: Gare aux effets indésirables parfois graves de l'exénatideLa Revue Prescrire. 2013, Vol 33, Num 352, issn 0247-7750, p. 97Article

Omega-3 Fatty Acids and Mortality Outcome in Patients With and Without Type 2 Diabetes After Myocardial Infarction: A Retrospective, Matched-Cohort StudyPOOLE, Chris D; HALCOX, Julian P; JENKINS-JONES, Sara et al.Clinical therapeutics. 2013, Vol 35, Num 1, pp 40-51, issn 0149-2918, 12 p.Article

Regional gastrointestinal delivery of remogliflozin etabonate in humansO'CONNOR-SEMMES, Robin L; SANDEFER, Erik P; HUSSEY, Elizabeth K et al.Biopharmaceutics & drug disposition. 2013, Vol 34, Num 2, pp 79-86, issn 0142-2782, 8 p.Article

The effects of statins on the clinical outcomes of Clostridium difficile infection in hospitalised patientsPARK, S. W; CHOI, A. R; LEE, H. J et al.Alimentary pharmacology & therapeutics. 2013, Vol 38, Num 6, pp 619-627, issn 0269-2813, 9 p.Article

Dapagliflozine ^(FORXIGA°): Un hypoglycémiant aux risques disproportionnés, notamment rénauxLa Revue Prescrire. 2013, Vol 33, Num 361, pp 813-814, issn 0247-7750, 2 p.Article

Linagliptine + metformine (JENTADUETO°): Écarter les gliptines, seules ou associéesLa Revue Prescrire. 2013, Vol 33, Num 354, issn 0247-7750, p. 255Article

La Vitamine CBUREAU, Loïc.La Phytothérapie européenne. 2013, Num 77, pp 8-12, issn 1628-6847, 5 p.Article

A new class of prolylcarboxypeptidase inhibitors, Part 2: The aminocyclopentanesGRAHAM, Thomas H; WENSHENGLIU; HUAIBING HE et al.Bioorganic & medicinal chemistry letters (Print). 2012, Vol 22, Num 8, pp 2818-2822, issn 0960-894X, 5 p.Article

Bromophenols as inhibitors of protein tyrosine phosphatase 1B with antidiabetic propertiesDAYONG SHI; JING LI; BO JIANG et al.Bioorganic & medicinal chemistry letters (Print). 2012, Vol 22, Num 8, pp 2827-2832, issn 0960-894X, 6 p.Article

Discovery of novel and potent heterocyclic carboxylic acid derivatives as protein tyrosine phosphatase 1B inhibitorsBASU, Sujay; VIPLAVA PRASAD, Uppuleti; WAMAN, Yogesh et al.Bioorganic & medicinal chemistry letters (Print). 2012, Vol 22, Num 8, pp 2843-2849, issn 0960-894X, 7 p.Article

New 4-[(5-arylidene-2-arylimino-4-oxo-3-thiazolidinyl)methyl]benzoic acids active as protein tyrosine phosphatase inhibitors endowed with insulinomimetic effect on mouse C2C12 skeletal muscle cellsOTTANA, Rosaria; MACCARI, Rosanna; AMUSO, Simona et al.European journal of medicinal chemistry. 2012, Vol 50, pp 332-343, issn 0223-5234, 12 p.Article

Synthesis and evaluation of piperidine urea derivatives as efficacious 11β-hydroxysteroid dehydrogenase type 1 inhibitors in diabetic ob/ob miceLIMING ZHANG; JUNHUA CHEN; MENGMENG NING et al.Bioorganic & medicinal chemistry letters (Print). 2012, Vol 22, Num 8, pp 2748-2752, issn 0960-894X, 5 p.Article

Conformationally constrained farnesoid X receptor (FXR) agonists: Heteroaryl replacements of the naphthaleneBASS, Jonathan Y; CARAVELLA, Justin A; NAVAS, Frank et al.Bioorganic & medicinal chemistry letters (Print). 2011, Vol 21, Num 4, pp 1206-1213, issn 0960-894X, 8 p.Article

Design of potent and selective GPR119 agonists for type II diabetesSZEWCZYK, Jason W; ACTON, John; MURPHY, Elizabeth et al.Bioorganic & medicinal chemistry letters (Print). 2011, Vol 21, Num 9, pp 2665-2669, issn 0960-894X, 5 p.Article

Discovery of benzimidazole pyrrolidinyl amides as prolylcarboxypeptidase inhibitorsSHEN, Hong C; DING, Fa-Xiang; BHATT, Urmi R et al.Bioorganic & medicinal chemistry letters (Print). 2011, Vol 21, Num 5, pp 1299-1305, issn 0960-894X, 7 p.Article

Discovery of novel and orally active FXR agonists for the potential treatment of dyslipidemia & diabetesRICHTER, Hans G. F; BENSON, Gregory M; PLANCHER, Jean-Marc et al.Bioorganic & medicinal chemistry letters (Print). 2011, Vol 21, Num 1, pp 191-194, issn 0960-894X, 4 p.Article

Effect of structurally constrained oxime―ether linker on PPAR subtype selectivity: Discovery of a novel and potent series of PPAR-pan agonistsMAKADIA, Pankaj; SHAH, Shailesh R; GIRI, Suresh et al.Bioorganic & medicinal chemistry. 2011, Vol 19, Num 2, pp 771-782, issn 0968-0896, 12 p.Article

Identification and optimization of tetrahydro-2H-3-benzazepin-2-ones as squalene synthase inhibitorsGRIEBENOW, Nils; FLESSNER, Timo; BUCHMUELLER, Anja et al.Bioorganic & medicinal chemistry letters (Print). 2011, Vol 21, Num 8, pp 2554-2558, issn 0960-894X, 5 p.Article